Radio and PodcastRadio and PodcastLive Radio & Podcasts
153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply artwork
Science & Medicine

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply

New FDA Approvals

Jun 21, 201811:03Science & Medicine

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attac...

About This Episode

153 - ACX-362E for CDI; Cosentyx and inhibition of joint damage progression; new assays from Grifols; personalized optimization of insulin pump therapy; FDA and drug shortages for critical products; FDA guidance on attacks on food supply is...

Podcast

This episode belongs to New FDA Approvals.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 21, 2018, 11:03 long, audio available.